Displaying 97 - 108 of 183
Immune-Mediated and Cholestatic Diseases
1

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Displaying 97 - 108 of 183